ARCHIVES

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal

November 4, 1983

Will Latest Report By Rosenberg Stir Up Critics? Some DCT Board Members Defend the Press

April 10, 1987

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

In Brief: NCI Gets $937 Million For FY 79 As Congress Adjourns; Cancer Act Renewed For Two Years

October 20, 1978

In Brief: Panel To Select Breast Committee Forom 130 Nominations; Bristol Plans Move To Princeton

December 6, 1991

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

November 9, 1990